ClinicalTrials.govpublic full text
Phase I Study of GSK2982772 in Japanese Healthy Male Participants
autoimmune diseases, sentinel-dosing, gsk2982772, japnese, dose-ascending, crossover, healthy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 991994
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.